Actions from Pharmaceutical Companies to Preserve Hydroxychloroquine (Plaquenil) Supply
March 30, 2020
The rheumatology community has been in discussions with the U.S. Food and Drug Administration and many pharmaceutical...
hydroxychloroquine
MARCH 26 STATEMENT: Lupus Research Alliance Puts Plaquenil (Hydroxychloroquine) Shortage into Perspective for Lupus Community
March 26, 2020
The Lupus Research Alliance (LRA), the world’s leading research organization dedicated to lupus research, continues to watch...
CVS Preserving Plaquenil Supply for Patients Taking It
March 26, 2020
CVS put out the following statement yesterday assuring its clients that the company is protecting a supply...
Hydroxychloroquine: Common Lupus Drug in Testing for COVID-19
March 19, 2020
In December 2019, a new virus called SARS-COV-2 was identified in Wuhan, China. This virus was found...
COVID-19 Frequently Asked Questions: What You Should Know
Updated April 3, 2020
The first priority of the Lupus Research Alliance is the health of our lupus community. We...
Potential New Lupus Treatment Outperforms Hydroxychloroquine in Animal Study
November 28, 2018
Anti-malaria drugs such as hydroxychloroquine are common treatments for arthritis and heat rash in patients with lupus....